SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001100412-18-000019
Filing Date
2018-08-07
Accepted
2018-08-07 08:15:13
Documents
8
Period of Report
2018-08-07
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 8.7.2018 a8720188kpressrelease.htm 8-K 36025
2 EXHIBIT 99.1 a872018breakthroughthera.htm EX-99.1 20823
3 a872018breakthroughthera001.jpg GRAPHIC 235744
4 a872018breakthroughthera002.jpg GRAPHIC 284058
5 a872018breakthroughthera003.jpg GRAPHIC 256889
6 a872018breakthroughthera004.jpg GRAPHIC 258122
7 a872018breakthroughthera005.jpg GRAPHIC 165388
8 a8720188kpressrelease_image1.jpg GRAPHIC 146580
  Complete submission text file 0001100412-18-000019.txt   1913312
Mailing Address 3200 WALNUT STREET BOULDER CO 80301
Business Address 3200 WALNUT STREET BOULDER CO 80301 3033816600
ARRAY BIOPHARMA INC (Filer) CIK: 0001100412 (see all company filings)

IRS No.: 841460811 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 8-K | Act: 34 | File No.: 001-16633 | Film No.: 18996363
SIC: 2834 Pharmaceutical Preparations